Tilray’s Aphria RX gets Cannabis trading license in Germany
by
Contributor since / Followers
Contributor since / Followers
2 months ago
EMS-FORSTER-PRODUCTIONS
- Tilray Brands (NASDAQ:TLRY) Monday said that Aphria RX GmbH has received a trading license, which will allow it to sell and distribute a broad range of medical cannabis products to pharmacies, hospitals, and medical wholesalers throughout Germany.
- With both cannabis cultivation and trade licenses, Tilray (TLRY) is now in a strong position to fully leverage the growing market opportunity in Germany, further expanding Tilray’s position as a global leader in cannabis research, cultivation, production, and distribution, the company added.
- TLRY +0.55% premarket to $1.84.
- Source: Press Release